Coca-Cola Co (NYSE: KO) (Q4) EPS of 51 cents, compared to 49 cents in the prior-year quarter. S&P Global Inc (NYSE: SPGI) (Q4) EPS of $3.41 compared to $3.13 in the prior-year quarter.

On CRSP's fourth-quarter 2024 earnings call, investors' focus will likely be on the sales figure of Casgevy, its first marketed product.

This was the stock's second consecutive day of losses.

Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...

In this article, we are going to take a look at where Lexicon Pharmaceuticals ... Mr. Coiante is a senior finance executive with more than 35 years of experience in the life science and ...